2021 Japan HIV/AIDS Diagnostics Market Assessment: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

2021 Japan HIV/AIDS Diagnostics Market Assessment: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

  • April 2021 •
  • Report ID: 6061697 •
  • Format: PDF
2021 Japan HIV/AIDS Diagnostics Market Assessment: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

This unique report provides information and analysis not available from any other published source.

The report is available by section, and can be customized to specific information needs and budget.

This report presents Japanese test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:

    - Hospitals
    - Commercial/Private Labs
    - Blood Banks

The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/JandJ, Roche, and Siemens.

List of Tables


Table 1  Major Companies Developing or Marketing AIDS Tests
Table 2  Japan: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3  Japan: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4  Japan: Western Blot Tests Volume and Sales Forecast by Market Segment
Table 5  Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6  Japan: AIDS Diagnostics Market by Major Supplier
Table 7  Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Contains 60 pages and 7 tables